Friedman et al. demonstrated that cell lines derived from ATCs are CD133+, and when transplanted in immunodeficient non-obese diabetic (NOD)/severe combined Immunodeficiency (SCID) mice, they are able to develop tumor (29). The gene discussed is PROM1; the disease is neoplasm.